Isovasc Medical is developing technologies to facilitate targeted trans-arterial drug delivery, combined with perfusion and filtration techniques, thereby potentially increasing efficacy and quality of life for cancer patients.

We are initially, primarily focused on European markets.

Why work with us

We are focused on delivering a unique product offering to our customers in the Interventional Oncology sector, providing Interventional Oncologists with greater options for their patients in respect to the targeted delivery of chemotherapy agents.